HIV protease inhibitors are disclosed which are characterized as having both hydroxyethylamine and N-heterocyclic moieties.

 
Web www.patentalert.com

< Methods for treatment of acute lymphocytic leukemia

< Method and composition for the diagnosis of equine infectious anemia virus disease by using the recombinant capsid protein virus (p26)

> Compositions and methods of double-targeting virus infections and cancer cells

> Methods for preventing and treating cancer using N-thiolated -lactam compounds and analogs thereof
~ 00252